Gwen A. Fyfe Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Gwen A. Fyfe.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Gwen A. Fyfe. Gwen A. Fyfe is Director in PHARMACYCLICS INC ($PCYC) and Director in INFINITY PHARMACEUTICALS, INC. ($INFI) and in ARRAY BIOPHARMA INC ($ARRY) and Director in ARRAY BIOPHARMA INC ($ARRY) and Director in Cascadian Therapeutics, Inc. ($ONTY).
Latest Insider Trading Transactions of Gwen A. Fyfe
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ARRY, CASC, INFI, PCYC
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Fyfe Gwen A. | Director | Option Exercise | D | 14.55 | 25,000 | 363,750 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Fyfe Gwen A. | Director | Option Exercise | D | 10.47 | 25,000 | 261,750 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Fyfe Gwen A. | Director | Option Exercise | D | 5.95 | 25,000 | 148,750 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Fyfe Gwen A. | Director | Option Exercise | D | 5.13 | 25,000 | 128,250 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Fyfe Gwen A. | Director | Option Exercise | D | 3.87 | 25,000 | 96,750 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Fyfe Gwen A. | Director | Option Exercise | D | 5.60 | 25,000 | 140,000 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Fyfe Gwen A. | Director | Option Exercise | D | 4.36 | 20,000 | 87,200 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Fyfe Gwen A. | Director | Option Exercise | D | 2.60 | 20,000 | 52,000 | 0 | |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Fyfe Gwen A. | Director | Sell | D | 0.00 | 5,000 | 0 | 0 | 5 K to 0 (-100.00 %) |
| Jul 30 2019 | ARRY | ARRAY BIOPHARMA IN ... | Fyfe Gwen A. | Director | Sell | D | 48.00 | 15,000 | 720,000 | 5,000 | 20 K to 5 K (-75.00 %) |
| Oct 29 2018 | ARRY | ARRAY BIOPHARMA IN ... | Fyfe Gwen A. | Option Exercise | M | 0.00 | 5,000 | 0 | 0 | ||
| Oct 29 2018 | ARRY | ARRAY BIOPHARMA IN ... | Fyfe Gwen A. | Option Exercise | A | 0.00 | 5,000 | 0 | 5,000 | ||
| Oct 29 2018 | ARRY | ARRAY BIOPHARMA IN ... | Fyfe Gwen A. | Option Exercise | A | 14.55 | 25,000 | 363,750 | 25,000 | ||
| Oct 29 2018 | ARRY | ARRAY BIOPHARMA IN ... | Fyfe Gwen A. | Buy | M | 0.00 | 5,000 | 0 | 15,000 | 10 K to 15 K (+50.00 %) | |
| Mar 13 2018 | CASC | Cascadian Therapeu ... | Fyfe Gwen A. | Director | Option Exercise | D | 0.00 | 13,927 | 0 | 0 | |
| Mar 13 2018 | CASC | Cascadian Therapeu ... | Fyfe Gwen A. | Director | Sell | U | 0.00 | 10,125 | 0 | 0 | 10.1 K to 0 (-100.00 %) |
| Oct 27 2017 | ARRY | ARRAY BIOPHARMA IN ... | Fyfe Gwen A. | Option Exercise | M | 0.00 | 5,000 | 0 | 0 | ||
| Oct 27 2017 | ARRY | ARRAY BIOPHARMA IN ... | Fyfe Gwen A. | Option Exercise | A | 0.00 | 5,000 | 0 | 5,000 | ||
| Oct 27 2017 | ARRY | ARRAY BIOPHARMA IN ... | Fyfe Gwen A. | Option Exercise | A | 10.47 | 25,000 | 261,750 | 25,000 | ||
| Oct 27 2017 | ARRY | ARRAY BIOPHARMA IN ... | Fyfe Gwen A. | Buy | M | 10.47 | 5,000 | 52,350 | 10,000 | 5 K to 10 K (+100.00 %) | |
| Jun 27 2017 | CASC | Cascadian Therapeu ... | Fyfe Gwen A. | Director | Option Exercise | M | 0.00 | 9,058 | 0 | 0 | |
| Jun 27 2017 | CASC | Cascadian Therapeu ... | Fyfe Gwen A. | Director | Payment of Exercise | F | 3.78 | 2,265 | 8,562 | 10,125 | 12.4 K to 10.1 K (-18.28 %) |
| Jun 27 2017 | CASC | Cascadian Therapeu ... | Fyfe Gwen A. | Director | Buy | M | 0.00 | 9,058 | 0 | 12,390 | 3.3 K to 12.4 K (+271.85 %) |
| Jun 13 2017 | CASC | Cascadian Therapeu ... | Fyfe Gwen A. | Director | Option Exercise | A | 0.00 | 13,927 | 0 | 13,927 | |
| Mar 30 2017 | CASC | Cascadian Therapeu ... | Fyfe Gwen A. | Director | Buy | P | 4.12 | 1,666 | 6,857 | 3,332 | 1.7 K to 3.3 K (+100.00 %) |
| Oct 31 2016 | ARRY | ARRAY BIOPHARMA IN ... | Fyfe Gwen A. | Option Exercise | M | 0.00 | 5,000 | 0 | 0 | ||
| Oct 31 2016 | ARRY | ARRAY BIOPHARMA IN ... | Fyfe Gwen A. | Option Exercise | A | 5.95 | 25,000 | 148,750 | 25,000 | ||
| Oct 31 2016 | ARRY | ARRAY BIOPHARMA IN ... | Fyfe Gwen A. | Option Exercise | A | 0.00 | 5,000 | 0 | 5,000 | ||
| Oct 31 2016 | ARRY | ARRAY BIOPHARMA IN ... | Fyfe Gwen A. | Buy | M | 5.83 | 5,000 | 29,150 | 5,000 | 0 to 5 K | |
| Jun 28 2016 | ONTY | Cascadian Therapeu ... | Fyfe Gwen A. | Director | Option Exercise | A | 0.00 | 54,347 | 0 | 54,347 | |
| Nov 02 2015 | ARRY | ARRAY BIOPHARMA IN ... | Fyfe Gwen A. | Option Exercise | A | 5.13 | 25,000 | 128,250 | 25,000 | ||
| Nov 02 2015 | ARRY | ARRAY BIOPHARMA IN ... | Fyfe Gwen A. | Option Exercise | A | 0.00 | 5,000 | 0 | 5,000 | ||
| Jun 16 2015 | INFI | INFINITY PHARMACEU ... | Fyfe Gwen A. | Director | Option Exercise | A | 11.06 | 15,000 | 165,900 | 15,000 | |
| Dec 13 2010 | PCYC | PHARMACYCLICS INC | Fyfe Gwen A. | Director | Option Exercise | A | 5.81 | 20,000 | 116,200 | 20,000 | |
| Dec 13 2010 | PCYC | PHARMACYCLICS INC | Fyfe Gwen A. | Director | Option Exercise | A | 5.76 | 10,000 | 57,600 | 10,000 |
Page: 1